CoreWeave, IREN, and Arm Holdings each fell more than 3% in morning trading on October 8, but for three separate reasons. CoreWeave is weighed down by a fresh capital raise and a debt covenant disclosure, IREN is fighting infrastructure criticism, and Arm is awaiting a jury verdict in its royalty dispute with Qualcomm. A risk-off macro backdrop is adding pressure to all three.
Three different setbacks are driving the declines, even as rising Treasury yields set a hostile backdrop for high-growth technology names generally.
CoreWeave slides on dilution and a debt-covenant disclosure
CoreWeave fell nearly 4.0% after launching an at-the-market equity program covering up to 35 million shares. The company also unveiled a $3.0 billion private offering of convertible senior notes due 2033 the prior session.
A fresh report also detailed a clause in CoreWeave's $2.6 billion AI infrastructure loan: a serious uptime or service failure could let a customer walk away from a contract backing the financing, forcing early debt repayment. The company carries roughly $35 billion in total debt and about $640 million in quarterly interest expense, costs still outpacing operating income despite rapid revenue growth.
Northland nonetheless raised its price target to $200 and named CoreWeave a top pick, citing valuation against contracted revenue. The company separately announced a 240 MW India data center partnership with AdaniConneX.
IREN extends its decline on infrastructure criticism
IREN fell 4.3% to $37.03, extending a slide that began after SemiAnalysis published posts questioning the reliability of the company's older data centers in Prince George and Mackenzie, British Columbia. The firm cited customer reports of multi-day power outages, network disruptions, and storage failures, a critique that had already sent the stock down more than 6% on Wednesday.
A bearish note published today added dilution risk from IREN's at-the-market program and negative free cash flow to the list of concerns. SemiAnalysis separately called on the company to revise its disclosures after IREN's commercial chief acknowledged no live managed cloud services are currently operational. The stock is now well below its 52-week high of $76.87.
Arm falls as the Qualcomm trial nears a verdict
Arm Holdings slid 3.8% to $283.25 as a five-day jury trial in Delaware, now in its final days, weighs on sentiment. Qualcomm is seeking to stop paying Arm royalties for up to five years, a remedy analysts estimate could be worth billions.
Qualcomm alleges Arm withheld chip-testing tools owed under their license agreement and leaked a 2024 termination threat to the press, which it says cut roughly $170 million from a Meta Platforms chip deal. Arm's CFO also sold more than 10,000 shares in a pre-planned trade in late September.
A hostile macro backdrop
Rising Treasury yields ahead of the September FOMC minutes are pushing investors away from capital-intensive growth names generally. The Nasdaq Composite is down 0.6% today. The S&P 500 is down 0.4% over the same stretch.
That backdrop is hitting debt-laden, highly leveraged AI infrastructure names hardest, compounding the pressure each of the three stocks already faces on its own.
Sources: Investing.com, Investing.com, Investing.com
Trading involves risk.
Risk Disclaimer
